Expanded Access for Iberdomide

Sponsor
Bristol-Myers Squibb
Study ID
NCT07434960
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Iberdomide for eligible participants.

Key Dates

Status verified
Feb 2026

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain the NCT# and Site #.